Revolution Medicines (RVMDW) News Today $5.40 +0.30 (+5.88%) Closing price 03:57 PM EasternExtended Trading$5.25 -0.15 (-2.76%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock RVMDW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Penumbra (PEN) and BioCryst (BCRX)May 9, 2026 | theglobeandmail.comHow FDA Expanded Access for Daraxonrasib and Phase 3 Survival Data At Revolution Medicines (RVMD) Has Changed Its Investment StoryMay 6, 2026 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL) and Revolution Medicines (RVMD)May 5, 2026 | theglobeandmail.comMizuho Securities Keeps Their Buy Rating on Revolution Medicines (RVMD)April 28, 2026 | theglobeandmail.comRevolution Medicines (RVMD) price target increased by 29.89% to 177.75April 28, 2026 | msn.comRevolution Medicines rival Erasca falls after early-stage trial data for cancer therapyApril 28, 2026 | msn.comAssessing Revolution Medicines (RVMD) Valuation After Positive RASolute 302 And Zoldonrasib Clinical UpdatesApril 28, 2026 | finance.yahoo.com5 Stocks With Monster ReturnsApril 20, 2026 | insidermonkey.comRevolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial ResultsApril 20, 2026 | finance.yahoo.comRevolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of ...April 17, 2026 | markets.businessinsider.comRevolution Medicines (RVMD) Is Up 42.9% After Phase 3 Daraxonrasib Survival Data And $750M Equity Raise – Has The Bull Case Changed?April 14, 2026 | finance.yahoo.comRevolution Medicines stock surges on pancreatic cancer trialApril 13, 2026 | investing.comRevolution Medicines' experimental cancer pill boosts survival in late-stage studyApril 13, 2026 | msn.comRevolution Medicines (RVMD) soars to all-time high on stellar cancer treatment trialApril 13, 2026 | msn.comRevolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?April 13, 2026 | finance.yahoo.comRevolution Medicines (RVMD) Gets a Buy from RBC CapitalApril 12, 2026 | theglobeandmail.comRevolution, Ascendis, Arrowhead among RBC’s top M&A candidates in biotechMarch 19, 2026 | msn.comRevolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR ...March 17, 2026 | markets.businessinsider.comIs RVMD’s Big Losses and Massive Equity Plans Reshaping the Investment Case for Revolution Medicines (RVMD)?February 27, 2026 | uk.finance.yahoo.comEvercore ISI Initiates Revolution Medicines (RVMD) With an Outperform Rating – Here’s WhyFebruary 26, 2026 | msn.comRevolution Medicines shares slide after Merck reportedly walks away from takeover talksJanuary 26, 2026 | msn.comRevolution Medicines stock falls after Merck reportedly ends acquisition pursuitJanuary 26, 2026 | finance.yahoo.comIs It Too Late To Consider Revolution Medicines (RVMD) After Its 187% One-Year Surge?January 26, 2026 | finance.yahoo.comBank of America Securities Sticks to Its Buy Rating for Revolution Medicines (RVMD)January 14, 2026 | theglobeandmail.comRevolution Medicines (RVMD) price target increased by 10.10% to 92.82January 14, 2026 | msn.comRevolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32BJanuary 12, 2026 | msn.comAnalysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Roche Holding AG (OtherRHHVF) and Monte Rosa Therapeutics (GLUE)January 12, 2026 | theglobeandmail.comAbbVie says not in talks to buy Revolution Medicines - reportJanuary 7, 2026 | msn.comRevolution Medicines price target raised to $98 from $82 at BofAJanuary 6, 2026 | msn.comRevolution Medicines announces first patient randomized in RASolute 304 trialDecember 18, 2025 | msn.comFDA Breakthrough Status For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD)December 12, 2025 | finance.yahoo.comStifel Nicolaus Sticks to Their Buy Rating for Revolution Medicines (RVMD)November 14, 2025 | theglobeandmail.comRBC Capital Keeps Their Buy Rating on Revolution Medicines (RVMD)November 14, 2025 | theglobeandmail.comTruist Financial Keeps Their Buy Rating on Revolution Medicines (RVMD)November 14, 2025 | theglobeandmail.comRevolution Medicines outlines multiple Phase III trial launches and commercial buildout amid increased R&D investmentNovember 5, 2025 | msn.comRevolution Medicines Inc (RVMD) Q3 2025: Everything You Need To Know Ahead Of EarningsNovember 4, 2025 | finance.yahoo.comRevolution Medicines a new outperform at RBC on RAS(ON) inhibitors for cancersNovember 4, 2025 | msn.comRBC Capital Initiates Coverage of Revolution Medicines (RVMD) with Outperform RecommendationNovember 4, 2025 | msn.comRevolution Medicines initiated with an Outperform at RBC CapitalNovember 3, 2025 | msn.comMizuho Initiates Coverage of Revolution Medicines (RVMD) with Outperform RecommendationOctober 22, 2025 | msn.comRevolution Medicines (RVMD): Examining Valuation After Recent Stock Momentum and Long-Term GainsOctober 20, 2025 | finance.yahoo.comJim Cramer Says Revolution Medicines “Is a Speculative Situation”October 19, 2025 | msn.comStifel Reiterates Revolution Medicines (RVMD) Buy RecommendationOctober 17, 2025 | msn.comRevolution Medicines resumed with a Buy at StifelOctober 15, 2025 | msn.comRevolution Medicines price target raised to $71 from $70 at JPMorganSeptember 25, 2025 | msn.comOppenheimer Remains a Buy on Revolution Medicines (RVMD)September 14, 2025 | theglobeandmail.comH.C. Wainwright Sticks to Its Buy Rating for Revolution Medicines (RVMD)September 14, 2025 | theglobeandmail.comRevolution Medicines resumed with a Strong Buy at Raymond JamesSeptember 12, 2025 | msn.comS&P 500 Futures Climb in Premarket Trading; Avidity Biosciences, Installed Bldg Products LagSeptember 11, 2025 | barrons.comRevolution Medicines price target raised to $70 from $67 at Wells FargoSeptember 11, 2025 | msn.com Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RVMDW Media Mentions By Week RVMDW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVMDW News Sentiment▼0.000.39▲Average Medical News Sentiment RVMDW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVMDW Articles This Week▼01▲RVMDW Articles Average Week Get the Latest News and Ratings for RVMDW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Revolution Medicines and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today enGene News Today Fortress Biotech News Today Humacyte News Today Jasper Therapeutics News Today NewAmsterdam Pharma News Today Nutriband News Today Rocket Pharmaceuticals News Today XOMA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVMDW) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
